Christopher M. Bussineau
Direttore operativo presso BioVascular, Inc.
Profilo
Christopher M.
Bussineau is currently the Vice President-Pharmaceutical Operations at BioVascular, Inc. He previously worked as the Senior Director-Technical Operations at Chiron Corp.
and as the Vice President & General Manager at Cambrex Bio Science Baltimore, Inc. Bussineau holds a doctorate degree from Rice University and an undergraduate degree from the University of California San Diego.
Posizioni attive di Christopher M. Bussineau
| Società | Posizione | Inizio |
|---|---|---|
BioVascular, Inc.
 BioVascular, Inc. Pharmaceuticals: MajorHealth Technology BioVascular, Inc. develops drugs and devices for control of intimal hyperplasia associated with vascular procedures. It is a integrated specialty cardiovascular therapeutic company, and to utilize corporate partnerships in markets that have complex marketing barriers and/or combination technologies. The company was founded by John H. Parrish and Paul F. Glidden in 2005 and is headquartered in San Diego, CA. | Direttore operativo | - |
Precedenti posizioni note di Christopher M. Bussineau
| Società | Posizione | Fine |
|---|---|---|
| Cambrex Bio Science Baltimore, Inc. | Corporate Officer/Principal | - |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Christopher M. Bussineau
| Rice University | Doctorate Degree |
| University of California San Diego | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
BioVascular, Inc.
BioVascular, Inc. Pharmaceuticals: MajorHealth Technology BioVascular, Inc. develops drugs and devices for control of intimal hyperplasia associated with vascular procedures. It is a integrated specialty cardiovascular therapeutic company, and to utilize corporate partnerships in markets that have complex marketing barriers and/or combination technologies. The company was founded by John H. Parrish and Paul F. Glidden in 2005 and is headquartered in San Diego, CA. | Health Technology |
| Cambrex Bio Science Baltimore, Inc. |
- Borsa valori
- Insiders
- Christopher M. Bussineau
